Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


INTERVIEW: Pre Diagnostics takes new approach to Alzheimer's blood test

This article was originally published in Scrip

Executive Summary

As the focus in Alzheimer's moves ever more towards treating early disease, there has been a parallel upswing in diagnostics companies and researchers developing blood tests for Alzheimer's disease. One firm, Norway's Pre Diagnostics, is taking a different approach that it believes will give it the edge over its rivals. Madeleine Armstrong spoke to chief scientific officer Frank Swenson



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts